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It is hypothesised that the characteristic twin domain structure or serine proteases pemlits important allosteric responses in the molecule when 
peptide and protein substrates bind. Such movement would be ideal for stressing the scissile bond in the substrate, thereby making the task of 
hydrolysis substantially easier. The control of the domain movement can be closely associated with substrate binding, via the N- and C-terminal 
regions of the enzyme. The hypothesis also suggests that certain inhibitory peptides exert their effect by binding without inducing the domain move- 
ment. 
Domain movement; Serine protease 
1. INTRODUCTION 
Many enzymes possess distinct domains in their 
superstructure and in several instances, relative move- 
ment of the domains is thought to be important for the 
entrance and exit of substrates and products [l], or the 
stressing of bonds that are required to be broken [2]. 
The trypsin-like serine proteases, a large family of pep- 
tide and protein cleaving enzymes, are superficially 
promising candidates for one to suspect such a con- 
tribution to their mechanism. To begin with they have 
two very marked domains in their structures. In a chain 
of approximately 240 residues, these two domains com- 
prise approximately residues l-120 and 121-240 
(Fig. 1). Secondly, perhaps the largest single obstacle to 
be overcome by the enzyme in its catalytic mechanism 
is the resonance energy stabilisation of the peptide 
bond (approx. 20 kcal/mol). The severity of conditions 
for the non-enzymic hydrolysis of peptide bonds is am- 
ple testimony to this. These enzymes are thought to sur- 
mount this obstacle by contriving to distort the peptide 
bond to be broken out of planarity [3], thereby produc- 
ing an ester-like character and consequent increased 
susceptibility to hydrolysis. In view of the precedents 
seen in other enzyme types, a reasonable possibility 
might be that the necessary peptide bond distortion is 
achieved mechanically in the serine proteases via a 
relative movement of the two large domains. 
This latter suggestion runs contrary to accepted 
wisdom, largely because there is such a wealth of struc- 
tural detail on these enzymes as complexed to a variety 
of peptide and protein inhibitors. These complexes are 
widely regarded as accurate models for the interaction 
with true substrates [4] and it is clear from them that 
the domains have not moved upon complexation as 
compared to the free enzyme. Consequently, the 
possibility of a large scale allosteric element to the 
mechanism is not entertained. 
However, as will be described below, there is reason 
to believe that the differences between a long-lived 
serine protease/inhibitor complex and a transient serine 
protease/substrate complex could be far more marked 
than the subtleties currently envisaged. 
2. IS THE SITUATION FAVOURABLE FOR 
DOMAIN MOVEMENT TO BE USEFUL? 
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In complexes uch as those of bovine pancreatic tryp- 
sin inhibitor with kallikrein [S], and turkey ovomucoid 
inhibitor with chymotrypsin [6], the inhibitor protein is 
bound across the two domains with the would-be 
‘scissile’ bond forming the point of cross-over from one 
domain to the other. As shown in Table I, virtually all 
of the inhibitor molecule bound N-terminal to the 
‘scissile’ bond interacts with the 121-240 domain while 
most interactions C-terminal to this bond occur with 
the l-120 domain. In the usual parlance adopted for 
these enzymes [7], the S,, SZ, &, etc. subsite com- 
ponents are largely located within the 121-240 domain 
while the Sf , S; , Sj etc. subsite components are largely 
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located within the l-120 domain. Thus, in terms of the 
essential requirements of a domain movement-induced 
bond stressing mechanism, the basic situation is 
favourable - the substrate~inhibitor is bound across 
both domains in such a way that if movement did oc- 
cur, the ‘scissile’ bond would be the natural focus of 
any stress that resulted. Nonetheless, the fact remains 
that the cross domain situation observed in the in- 
hibitor complexes has not aItered domain position. 
Thereby, the domain movement hypothesis can only re- 
main tenable if it is considered that the true Sn or Sn ’ 
subsites for substrates have not been correctly inferred. 
In other words, have the inhibitors that bridge the do- 
mains bound ‘wrongly’ to one of them as part of a 
modus operandi designed to prevent the stressing 
mechanism? 
3. SUBSTRATE INTERACTIONS IN THE 
l--120 DOMAIN 
From the extensive detail discovered about the 
hydrolysis of model substrates and the character of 
peptide inhibitors, the only feasible suggestion is that 
inhibitors like bovine trypsin inhibitor and turkey 
ovomucoid inhibitor are giving a false impression of 
both the nature and extent of Sn’ interactions (i.e., in- 
teractions that occur with the l-120 domain). As aiso 
shown in Table I, the degree of interaction in the Sr, SZ, 
S3 etc. subsites is much more extensive and exclusive 
with respect to the twin domain structure than is the S,‘, 
Si, Sj etc interaction, especially with regard to the Sr 
subsite. The importance of Sn’ interactions is often 
overlooked because they are clearly not essentiai for the 
hydrolysis of ester and primary amide substrates. 
However, when dealing strictly with peptides and pro- 
teins, there is a body of work that shows that Sn’ in- 
teractions are essential if a peptide bond proper is to be 
successfully dealt with [8,9]. A peptide/protein 
substrate is required to have at least two residues 
Table 1 





Inhibitor residues PKPI P/-P{ PcP1 Pi --Pj 
Enzyme domain 1 
(residues l-120) 4% 24% 6% 22% 
Enzyme domain 2 
(residues 121-240) 58% 14% 57% 15% 
Intermolecular contacts expressed as percentage of total number of 
contacts. P&-P, are the six residues N-terminal to the ‘scissile’ bond, 
while Pi-P; are the three residues C-terminal to this bond. Data 
from Chen and Bode [S] (kailikrein), and Fujinaga et ai. 161 
(chymotrypsin) 
10 
beyond the scissile bond (i.e., Si and Si occupancy) 
and rates of hydrolysis increase with successive site oc- 
cupancy (i.e., S; and beyond). Significantly, 
aminopeptidase and carboxyp~ptidase actions require 
completely different mechanisms - the serine proteases 
in question are strictly endopeptidases. 
There is thus little doubt that successful cleavage of 
a peptide bond depends on the substrate binding pro- 
perly to both the 121-240 domain (Sn sites) and the 
l-120 domain (Sn’ sites). If the Sn’ occupancy ex- 
trapolated from the inhibitor complexes is misleading 
in extent and location, what is the alternative? 
4. THE UNUSUAL SYMMETRY OF 
SERINE PROTEASES 
One of the most remarkable and enigmatic features 
of the twin domain structure of the serine proteases is 
the presence of an approximate two-fold symmetry 
with respect to the domain architecture. As a conse- 
quence, the chain fold of one domain can be superim- 
posed directly on to that of the other after a rotation 
through 180”. What makes this symmetry so unusual is 
that if the superimposition is carried out, the respective 
polypeptide chains of the two domains are found to run 
in opposite directions. In other words, the chain fold is 
palindromic in 3 dimensions either side of the crossover 
from one domain to the other (Fig. 1). This curiosity 
was noticed with the advent of the crystal structure of 
elastase [lo] and was explored by later authors [ 111, but 
has not been fully explained. As one of these works 
showed [I 11, the strength of the approximate two-fold 
synlmetry is best appreciated from a-carbon in- 
teratomic distance matrices, which contain a very ob- 
vious ‘mirror plane’ in the matrix pattern. It was also 
shown that the folding palindromy was not matched by 
Pig. 1. A schematic representation of the chain fold in the trypsin- 
like wine proteases, drawn to emphasise the two-fold domain 
symmetry present. .4 \iew down on to the active site is presented, the 
broken lines denoting portions of the chain furthest from the viewer 
while the shaded portions arc those closest. The double lines are 
disulphide bonds (that marked with an asterisk is absent in some 
variants). Note that this orientation is essentially unchanged in 
Fig. 2. 
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sequence palindromy. The presence of this symmetry 
element in the molecular fold creates a major connun- 
drum, for it is not possible with conventional wisdom 
to envisage a ‘deliberate’ evolutionary path that could 
have arrived at such a situation. Consequently, this 
symmetry is considered by some to be fortuitous, or ac- 
cidental [12], and therefore of no real relevance to any 
catalytic mechanism that has arisen in the molecule. 
However, whether or not the origins of this sym- 
metry can be satisfactorily accounted for, its presence 
in the molecule means that it is worthy of serious con- 
sideration. When a representative a-carbon interatomic 
distance map of a serine protease is considered, the ap- 
proximate two-fold domain symmetry in the molecule 
means that for any point or locality in one domain, an 
analogous point or locality can be identified in the op- 
posite domain by means of the ‘mirror plane’ present 
in the matrix pattern. In view of the lack of sequence 
palindromy in the two domains, the analogy is in terms 
of the surrounding main chain architecture, not 
chemical character. Thus for any substrate/inhibitor 
binding site found in one domain, there is a similarly 
shaped ‘twin’ in the opposite domain which differs in 
residue composition and polypeptide chain direction. 
This only applies fully to the secondary binding sites 
because the catalytic site itself (i.e., the triad of 
histidine 57, aspartate 102 and serine 195, as they are 
generally numbered) is constituted at the domain inter- 
Fig. 2. A simplified representation of inhibitor binding, showing the 
enzyme in a computer-generated ribbon form (only those segments 
nearest the viewer are shown) and the inhibitor as a carbon-nitrogen 
backbone without side chains (solid lines). It is based on the 
chymotrypsin/ovomucoid complex elucidated by Fujinaga et al. [61 
(see Fig. 16 in this reference). PI-Pj are the side chains on the N- 
terminal side of the ‘scissile’ bond (double lined) and P; -Pj are on 
the C-terminal side. The alternative positioning of residues Pi-Pi 
(white line) shows where binding would have to occur to complement 
the domain symmetry. Note the stretched ‘scissile’ bond (dotted 
lines). 
face from residue contributions from both sides. The 
Sn and Sn’ subsites, in contrast, tend to be wholly in 
one domain or the other. 
5. THE SYMMETRY AND SUBSTRATE/- 
INHIBITOR BINDING 
If the Sn and Sn’ binding sites and the ‘catalytic 
triad’ are appraised with respect to the approximate 
two-fold chain symmetry, it can be noted that: (a) The 
two most directly involved catalytic residues, histidine 
57 and serine 195, occupy almost equivalent positions 
in their respective domain folds. In other words, if the 
l- 120 and 121-240 domains are superimposed accor- 
ding to the approximate two-fold symmetry, histidine 
57 is approximately superimposed on serine 195; and 
(b) by way of contrast, the Sn and Sn’ subsites as cur- 
rently identified are not superposed by virtue of such a 
domain superimposition. Thus, inhibitors that bind 
across the domains do not do so in a way that com- 
plements the two-fold symmetry - the Sn’ interactions 
are less extensive and appear misplaced with respect to 
the Sn interactions. 
Fig. 2 is a representation of an enzyme inhibitor 
complex which shows the actual binding mode and 
where the P’n residues would have to bind to comple- 
ment the two-fold domain symmetry. If the Pn residues 
are regarded as optimally bound, it is clear that sym- 
metrical binding could only be achieved if either the do- 
mains were rotated with respect to one another and 
moved closer, or the ‘scissile’ bond were stretched and 
distorted. It is this that leads to the suspicion that by 
binding wrongly/inadequately to the 1- 120 domain, 
inhibitors prevent a mechanism in which the domains 
adjust to bind a true substrate and contrive a situation 
in which the scissile bond becomes the focus of con- 
straint against subsequent relaxation. A stressed pep- 
tide bond restraining the motion of two large domains 
is clearly a situation favourable for the loss of 
resonance energy and assisted bond cleavage. 
6. HOW MIGHT DOMAIN MOVEMENT BE 
CONTROLLED? 
‘The viability of such a hypothesis also depends on 
whether a suitable allosteric control can be envisaged. 
An inspection of the chain fold on purely mechanical 
principles shows that the major restraints on relative 
domain motion are likely to be the main chain termini, 
each of which protrudes from its parent domain to be 
bedded on the outer face of the other (Fig. I). The 
possibility that these termini effectively constitute the 
‘locks’ against domain movement has been strongly in- 
tirnated in theoretical analyses by Segawa and Richards 
[13], albeit in another context. In the native enzyme, 
they detected no chain flexibility near residue 120, 
where the main chain crosses from one domain to the 
11 
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other (and which lies directly under the scissile bond 
location). However, when the N and C termini sections 
were removed for their analysis, marked flexibility did 
appear near residue 120. Thereby, a prerequisite of do- 
main movement is a change in disposition of the N and 
C termini. A simple bringing together and/or slewing 
of the domains (as induced by a substrate) might 
achieve this, but there is more suggestive evidence from 
studies on the activation mechanisms of these enzymes. 
The crystal structures of trypsinogen, trypsin and 
bovine pancreatic trypsin inhibitor complexed to tryp- 
sinogen reveal an allosteric interplay between the 
disposition of the N-terminus of the enzyme and the 
conformational status of the SI binding subsite [ 14,151. 
In the trypsinogen-trypsin transition, removal of some 
N-terminal residues allows the new N-terminus to oc- 
cupy a special binding site in the 121-240 domain, the 
consequence of the binding being that the nearby SI 
substrate binding pocket is induced to adopt its recep- 
tive form [ 141. The two-fold symmetry in these enzymes 
also means that the C-terminal a-helix resides in a 
similar position relative to the ‘symmetry-twin’ of the 
S, pocket. When bovine pancreatic trypsin inhibitor 
binds to trypsinogen, conformational changes in the 
enzyme ensue which are very similar to those that occur 
when N-terminal activation occurs [15]. Aspartate 194 
is seen to rotate and the so-called ‘activation domain’ 
becomes rigid, forming both the S1 specificity pocket 
and the binding cleft for the enzyme’s N-terminus. 
Hence, not only can the N-terminal of the enzyme 
change the character of the S1 pocket, but also binding 
in the S1 pocket can change the character of the N- 
terminal binding cleft. This potential two-way com- 
munication between the S1 pocket and the N-terminus 
raises a very interesting question, namely: Could full 
binding of the substrate in the SI and S; pockets in- 
fluence the positions of the enzyme’s nearby N and C 
termini and thereby help to precipitate domain 
movements which ultimately contribute to cleavage? It 
is implicit in the overall mechanism proposed here that 
the substrate is responsible for bringing about domain 
movement and consequently its own breakdown. An 
‘induced fit’ aspect to the mechanism is therefore re- 
quired, so any suggestion of an allosteric interplay bet- 
ween substrate side chain binding and the induction of 
domain movement is highly relevant to the issue. 
7. SUMMARY OF HYPOTHESIS 
The general mechanistic hypothesis that emerges 
from the above discussion is one in which domain 
movement is paramount. It is suggested that in its un- 
complexed form, the enzyme has its domains ‘locked’ 
together by virtue of the enzyme’s N and C termini in- 
teracting with their binding sites on the outer faces of 
the two domains. Upon proper substrate binding, 
however, there are two factors which could lead to a 
12 
disengagement of these locks. Firstly, S1 and SI’ oc- 
cupancy by the substrate could allosterically alter the 
nature of the enzyme’s N and C terminal binding sites 
and reduce their affinity for the termini themselves. 
Secondly, the substrate’s desire to bind symmetrically 
across the two domains could bring the domains 
together. Because of the chain fold, this could transmit 
a direct mechanical impetus to the N and C termini of 
the enzyme to disengage. Both factors could augment 
each other, the net consequence being that the substrate 
induces its own fit and its scissile bond becomes one of 
only two peptidic links restraining the relative motion 
of the two large domains. However, whereas the en- 
zyme’s own peptidic domain connection describes a 
spring-like zig-zag (Fig. I), the substrate’s scissile bond 
would be held diagonally taught between the domains, 
flanked by histidine 57 and serine 195. Thereby, any 
subsequent desire of the two domains to move apart 
focusses stress on the scissile bond, and were the stress 
to distort the peptide bond geometry enough to 
significantly lessen the double-bond character of the 
carbon-nitrogen bond, successful attack by the 
‘catalytic’ residues would be greatly facilitated. As 
soon as the scissile bond breaks, the domains are free 
to move apart. By a reversal of the previous pathway, 
a mechanically forced re-engagement of the enzyme’s N 
and C termini in their normal binding sites could 
adversely affect the chemical hospitability of the S1 and 
S; binding pockets to the extent that the products 
might be encouraged to leave. With the dissociation of 
the products, the enzyme is restored to its original 
status with the domains locked. In contrast, inhibitor 
peptides/proteins may fail to induce the stressing 
mechanism because there is insufficient and/or incor- 
rect binding to one of the domains to ‘unlock’ the do- 
main movement. Consequently, the enzyme remains 
more or less in its resting state and the ‘stress factor’ 
contribution to the mechanism is lost. The efficiency of 
inhibitor hydrolysis is thus drastically reduced. 
8. CONCLUSION 
The arguments presented herein suggest that a 
significant part of the serine protease mechanism lies 
concealed behind an experimental ‘blindspot’ and, un- 
fortunately, it may be some time before the extremely 
transient events envisaged can be properly tested in the 
laboratory. Proof one way or the other will require pro- 
tein engineering experiments on the enzyme itself or an 
exhaustive computer simulation of all induced-fit 
possibilities between substrate and enzyme. However, 
by accepting that the potential for domain movement 
exists in the fold itself, and by following the symmetry 
aspects to their logical conclusion, there seems to be 
good prima facie case for an investigation along these 
lines. 
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